Evidence map›Paper›PMID 39847055›Full record

ReviewNaunyn-Schmiedeberg's archives of pharmacology2025

"Methyl jasmonate: bridging plant defense mechanisms and human therapeutics".

Garima Sharma, Badruddeen, Juber Akhtar, Mohammad Irfan Khan, Mohammad Ahmad, Prakash Kumar Sharma

Abstract readReview
PubMed Publisher
In one paragraph

Review in Naunyn-Schmiedeberg's archives of pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Garima SharmaFaculty of Pharmacy, Integral University, Kursi Road, Lucknow, U.P., 226026, India.
BadruddeenFaculty of Pharmacy, Integral University, Kursi Road, Lucknow, U.P., 226026, India. badarmiracle@gmail.com.
Juber AkhtarFaculty of Pharmacy, Integral University, Kursi Road, Lucknow, U.P., 226026, India.
Mohammad Irfan KhanFaculty of Pharmacy, Integral University, Kursi Road, Lucknow, U.P., 226026, India.
Mohammad AhmadFaculty of Pharmacy, Integral University, Kursi Road, Lucknow, U.P., 226026, India.
Prakash Kumar SharmaDepartment of Anesthesiology, Hind Institute of Medical Sciences, Safedabad, Lucknow, U.P., 225001, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A volatile organic substance produced from jasmonic acid, methyl jasmonate (MJ/MeJA), is an important plant hormone involved in stress responses and plant defense. Apart from its role in plants, MJ has garnered significant attention because of its pharmacological effects and possible therapeutic use in human health. This thorough analysis looks into the many biological actions of MJ, such as its antioxidant, anti-inflammatory, and anti-cancer effects. The underlying mechanism of these actions is examined, emphasizing MJ's ability to modulate important signaling pathways, cause cancer cells to undergo apoptosis, and boost immunological responses. Furthermore, MJ's capacity to manage long-term illnesses like cancer and neurological conditions like Parkinson's and Alzheimer's is examined. Preclinical and clinical research are beginning to provide evidence that MJ may be a useful medicinal drug. Nevertheless, more research is needed to fully understand its mode of action, enhance its administration methods, and evaluate its efficacy and safety in humans. This review highlights MJ's therapeutic promise and supports earlier research into its pharmacological capabilities and possible medical applications. This abstract highlights methyl jasmonate's pharmacological effects and therapeutic potential by providing a concise overview of the main topics covered in a thorough review.

Indexed as

AcetatesCyclopentanesOxylipinsPlant Growth RegulatorsAnimalsAnti-Inflammatory AgentsAntioxidantsHumansAcetatesAnti-Inflammatory AgentsAntioxidantsCyclopentanesmethyl jasmonateOxylipinsPlant Growth RegulatorsInflammatory biomarkersJasmonic acidMemory enhancementMethyl jasmonateModulatory effectNeurological disorders

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.